Personalized Regenerative Therapies
Broad portfolio including Lung Disease, Macular Degeneration, Alzheimer’s, Parkinson’s, Diabetes, Kidney Disease, etc.
Key Facts
About Cellino Biotech
Cellino Biotech is pioneering a closed-loop, autonomous manufacturing platform to scale personalized regenerative therapies. The company's proprietary technology stack combines AI, laser-based cell editing, and modular hardware (Nebula™) to overcome key bottlenecks in cell therapy: reproducibility, scalability, and the need for immunosuppression. By enabling distributed manufacturing of patient-specific iPSC-derived therapies, Cellino targets a broad pipeline of chronic degenerative conditions, positioning itself at the convergence of deep tech and biomedicine. The company is privately held and appears to be in a pre-clinical or platform development stage.
View full company profile